U.S. Regulation

Canary Capital Registers Staked Injective ETF in Delaware

The trust’s registration is just the beginning. To make the ETF officially recognized and listed, Canary Capital must file a Form S-1 registration statement with the U.S. Securities and Exchange Commission (SEC). This is a necessary procedure for obtaining approval from the SEC, which oversees securities offerings in the U.S. Once the Form S-1 is filed, the SEC will review the application before granting approval.

Additionally, Canary Capital will need to submit a Form 19b-4 filing. This filing will be made through the exchange where the ETF is intended to be listed. These filings are crucial steps toward bringing the ETF to market. As of now, the official filings are not yet available on the SEC website. Canary Capital has made prior filings with the SEC for other cryptocurrencies, including TRON (TRX), Sui (SUI), and PENGU.

These filings reflect the firm’s broader strategy of expanding its offerings in the crypto market by providing new investment opportunities tied to cryptocy assets. The Canary Staked Injective ETF aims to track the spot price of Injective (INJ), while also earning additional INJ tokens through staking. Staking is a process where holders of a cryptocy lock up their tokens to support network operations, such as transaction validation, in exchange for rewards.

In this case, investors in the ETF would gain exposure to both the market price of INJ and the staking rewards generated through the Injective blockchain just like the Solana ETF. This design offers convenience for investors since it allows investors to gain exposure to INJ without having to stake INJ directly. In doing this, this setup makes it easier for people who would like to participate through the staking rewards program but may not have the technical know how or interest in managing their own staking operations.

Canary Capital’s announcement comes amid other financial firms starting to offer similar crypto – backed investment products. In particular, 21Shares’s Injective Staking Exchange Traded Product (ETP), called AINJ, is a 100% physically backed product. While reinvesting staking rewards back into the ETP, AINJ tracks the performance of INJ.

This product is already on Euronext Amsterdam and Paris, enabling exposure to INJ and staking rewards for crypto investors. AINJ is asset backed by INJ tokens held in an institutionally grade custodian. Several prominent financial institutions including Interactive Brokers, Saxo Bank, Swissquote and eToro have supported this ETP.

Terron Gold

Recent Posts

Bitcoin Crashes Below $72,000 as BlackRock Leads $1.44 Billion ETF Selloff and Crypto Liquidations Surge

Bitcoin plunged below $72,000 on Thursday as institutional investors continued withdrawing money from U.S. spot…

4 days ago

Nvidia CEO Jensen Huang Resigns as Third Woman Emerges in Cheating Scandal Involving Alleged Chinese Spy

Nvidia co-founder and CEO Jensen Huang has resigned after 33 years leading the artificial intelligence…

4 days ago

BNY Partners With Figment to Bring Ethereum and Solana Staking to Institutional Investors

BNY (NYSE: BNY), one of the world's largest financial services and custody institutions, has partnered…

4 days ago

TRON, Tether and Chainalysis Launch New Crypto Crime Task Force After $450 Million Anti-Fraud Alliance Collapses

TRON, Tether and blockchain analytics company Chainalysis have launched the Digital Crime Task Force (DCTF),…

4 days ago

DOJ, Wall Street Banks and DeFi Giants Unite to Fight Illinois Crypto Transaction Tax

The U.S. Department of Justice (DOJ), major Wall Street banking organizations and leading decentralized finance…

4 days ago

OKX and NYSE Owner ICE Set November 23 Launch for Tokenized Stocks as Apple, Nvidia and Big Tech Opt Out

Cryptocy exchange OKX and Intercontinental Exchange (ICE), the parent company of the New York Stock…

5 days ago